Bulletin De L Academie Nationale De Medecine最新文献

筛选
英文 中文
Éléments de succès du modèle catalan-espagnol de don et de greffe d’organes 加泰罗尼亚-西班牙器官捐献和移植模式的成功因素
IF 0.3 4区 医学
Bulletin De L Academie Nationale De Medecine Pub Date : 2026-10-01 Epub Date: 2026-09-03 DOI: 10.1016/j.banm.2026.01.028
Chloë Ballesté Delpierre
{"title":"Éléments de succès du modèle catalan-espagnol de don et de greffe d’organes","authors":"Chloë Ballesté Delpierre","doi":"10.1016/j.banm.2026.01.028","DOIUrl":"10.1016/j.banm.2026.01.028","url":null,"abstract":"<div><div>Organ transplantation is a cornerstone therapy for end-stage organ failure, yet it remains constrained by graft scarcity. Recent international data show that global activity has largely recovered after the pandemic, while the gap between needs and available organs persists. In this landscape, Spain and within its framework, Catalonia, has been considered an international benchmark for decades. This performance appears to rely less on a single lever (legal framework, presumed consent, etc.) than on a coherent, system-wide strategy: three-tier governance, medically led hospital coordination, professionalization and training, quality management (audits, indicators, continuous improvement), aligned funding mechanisms, and sustained capacity for innovation in response to changing donor epidemiology. This general review summarizes these success factors in light of international and European recommendations (ethical principles, quality and safety requirements, traceability), and highlights Catalonia's contribution, including regional coordination mechanisms and the international dissemination of structured training programs (Total Productive Maintenance [TPM]) disseminated to international donors. Beyond the Spanish case, conditions for transferability are discussed: clear accountability, investment in competencies, transparency and public trust, and the use of comparable evaluation frameworks. These lessons support the design of organ donation promotion policies tailored to local contexts.</div></div>","PeriodicalId":55317,"journal":{"name":"Bulletin De L Academie Nationale De Medecine","volume":"210 8","pages":"Pages 901-906"},"PeriodicalIF":0.3,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149071990","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Actualités de la maladie d’Alzheimer 关于阿尔茨海默病的新闻
IF 0.3 4区 医学
Bulletin De L Academie Nationale De Medecine Pub Date : 2026-10-01 Epub Date: 2026-09-07 DOI: 10.1016/j.banm.2026.03.020
Bruno Dubois
{"title":"Actualités de la maladie d’Alzheimer","authors":"Bruno Dubois","doi":"10.1016/j.banm.2026.03.020","DOIUrl":"10.1016/j.banm.2026.03.020","url":null,"abstract":"","PeriodicalId":55317,"journal":{"name":"Bulletin De L Academie Nationale De Medecine","volume":"210 8","pages":"Pages 939-940"},"PeriodicalIF":0.3,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149071996","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Discussion à propos de la communication : « Éléments de succès du modèle catalan-espagnol de don et de greffe d’organes » 沟通讨论:“加泰罗尼亚-西班牙器官捐献和移植模式的成功因素”
IF 0.3 4区 医学
Bulletin De L Academie Nationale De Medecine Pub Date : 2026-10-01 Epub Date: 2026-07-27 DOI: 10.1016/j.banm.2026.07.011
Chloë Ballesté Delpierre
{"title":"Discussion à propos de la communication : « Éléments de succès du modèle catalan-espagnol de don et de greffe d’organes »","authors":"Chloë Ballesté Delpierre","doi":"10.1016/j.banm.2026.07.011","DOIUrl":"10.1016/j.banm.2026.07.011","url":null,"abstract":"","PeriodicalId":55317,"journal":{"name":"Bulletin De L Academie Nationale De Medecine","volume":"210 8","pages":"Pages 980-982"},"PeriodicalIF":0.3,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149072001","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardiomyopathie et fibrillation atriale. Du concept au diagnostic et à la stratification du risque cardiovasculaire 心肌病与心房纤颤。从概念到心血管风险的诊断和分层
IF 0.3 4区 医学
Bulletin De L Academie Nationale De Medecine Pub Date : 2026-10-01 Epub Date: 2026-08-26 DOI: 10.1016/j.banm.2026.06.016
Ariel Cohen, Théo Duro, Stéphane Ederhy, Lucas Benoudiba-Campanini, Stéphane N. Hatem, Estelle GANDJBAKHCH, Alban Redheuil, Franck Boccara, Laurie Soulat-Dufour
{"title":"Cardiomyopathie et fibrillation atriale. Du concept au diagnostic et à la stratification du risque cardiovasculaire","authors":"Ariel Cohen,&nbsp;Théo Duro,&nbsp;Stéphane Ederhy,&nbsp;Lucas Benoudiba-Campanini,&nbsp;Stéphane N. Hatem,&nbsp;Estelle GANDJBAKHCH,&nbsp;Alban Redheuil,&nbsp;Franck Boccara,&nbsp;Laurie Soulat-Dufour","doi":"10.1016/j.banm.2026.06.016","DOIUrl":"10.1016/j.banm.2026.06.016","url":null,"abstract":"&lt;div&gt;&lt;div&gt;Atrial cardiomyopathy is a pathophysiological concept corresponding to an abnormality of atrial substrate and function, defined by atrial dilation, altered myocyte function, and fibrosis, and constituting a thrombogenic milieu. Early atrial cardiomyopathy, followed secondarily by atrial fibrillation (AF), could be the cause of strokes, heart failure with preserved ejection fraction (HFpEF) and atrioventricular regurgitation. Atrial cardiomyopathy can be due to a primary condition, including genetics, without any other significant initial cardiac abnormalities, or secondary to pre-existing ventricular and/or valvular disease. Similar to ventricular cardiomyopathy, it presents a spectrum of varying severity, and the combination of different markers indicates an increased risk of progression. Atrial cardiomyopathy can manifest as abnormalities in the geometry, structure, and function of the atria. However, there are no universally accepted and documented thresholds for predicting the severity and consistency of these abnormalities. Furthermore, reference values are available for only a limited number of markers. A 12-lead electrocardiogram should be routinely performed to look for P-wave abnormalities. Frequent atrial premature beats identify patients at risk of developing atrial fibrillation and are associated with an increased risk of stroke and mortality. Transthoracic echocardiography is the standard for determining indexed left atrial volume and left atrial longitudinal strain, a precise and validated parameter for assessing atrial function, although threshold values remain a subject of debate. A thrombogenic milieu, defined by the presence of a left atrial thrombus, spontaneous echocardiographic contrast, and slow left atrial filling and emptying velocities, has been described with transesophageal echocardiography, however this semi-invasive examination is primarily performed in patients with atrial fibrillation or following a stroke of undetermined cause. Cardiac MRI is a validated tool for assessing left atrial morphology and volumes and is the gold standard for evaluating the extent of atrial fibrosis (late gadolinium enhancement), an independent predictor of AF, atrial dysfunction and cerebrovascular events. Cardiac computed tomography (CT) allows measurement of left atrial volumes, analysis of left atrial appendage anatomy and size, including the presence of a thrombus, and is the gold standard for left atrial appendage morphology. Circulating biomarkers (NT-proBNP, BNP, troponins) can reflect atrial inflammation and fibrosis. The primary therapeutic goal should be the prevention or reversal of deleterious atrial remodeling, based on the control of underlying risk factors, including hypertension, diabetes, obesity, and their consequences. Several drug classes have shown potential as “upstream” therapies, due to their anti-fibrotic and anti-inflammatory properties, such as renin-angiotensin-aldosterone system inhibitors, SGLT2 in","PeriodicalId":55317,"journal":{"name":"Bulletin De L Academie Nationale De Medecine","volume":"210 8","pages":"Pages 969-978"},"PeriodicalIF":0.3,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149072003","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nouvelle classification phénotypique des malformations vasculaires périphériques : actualisation ISSVA 2025 外周血管畸形的新表型分类:ISSVA 2025更新
IF 0.3 4区 医学
Bulletin De L Academie Nationale De Medecine Pub Date : 2026-10-01 Epub Date: 2026-08-12 DOI: 10.1016/j.banm.2026.02.014
Anne Dompmartin, Jean-Matthieu L’Orphelin
{"title":"Nouvelle classification phénotypique des malformations vasculaires périphériques : actualisation ISSVA 2025","authors":"Anne Dompmartin,&nbsp;Jean-Matthieu L’Orphelin","doi":"10.1016/j.banm.2026.02.014","DOIUrl":"10.1016/j.banm.2026.02.014","url":null,"abstract":"<div><h3>Objectives</h3><div>Vascular anomalies represent a very broad spectrum of pathologies, ranging from benign, localized skin lesions to complex and potentially life-threatening forms. The classification developed by the International Society for the Study of Vascular Anomalies (ISSVA) is now the international standard for terminology, diagnosis, and therapeutic approach. The ISSVA classification distinguishes between proliferative vascular tumors and non-proliferative vascular malformations. This system enables unified communication between pathologists, clinicians, and researchers, and facilitates the evaluation, diagnosis, and treatment of malformations according to their predominant vascular component, their flow (slow or fast), and their familial or sporadic nature.</div></div><div><h3>Methods and results</h3><div>Since the 2014 version, this classification has undergone several major updates, notably incorporating genetic discoveries in familial and sporadic forms, as well as the description of new entities defined by their phenotype and genotype. A working group was created in 2018 within the scientific committee to discuss the various aspects of the classification requiring modification. The 2025 version is the result of international collaboration between clinicians, pathologists, and geneticists, and includes provisional entities (PUVA) awaiting complete characterization. The creation of a dynamic glossary enriches the terminology, facilitating the use of the classification by all practitioners, from general practitioners to specialists.</div></div><div><h3>Conclusion</h3><div>This article focuses on the classification of vascular malformations, which is the area of major discoveries in etiopathogenesis. It will continue to evolve in order to accurately describe certain phenotypic and molecular patterns.</div></div>","PeriodicalId":55317,"journal":{"name":"Bulletin De L Academie Nationale De Medecine","volume":"210 8","pages":"Pages 890-894"},"PeriodicalIF":0.3,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149071987","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
La psychiatrie entre sciences humaines et sciences de la nature 人文和自然科学之间的精神病学
IF 0.3 4区 医学
Bulletin De L Academie Nationale De Medecine Pub Date : 2026-10-01 Epub Date: 2026-08-06 DOI: 10.1016/j.banm.2026.05.032
Bernard Granger
{"title":"La psychiatrie entre sciences humaines et sciences de la nature","authors":"Bernard Granger","doi":"10.1016/j.banm.2026.05.032","DOIUrl":"10.1016/j.banm.2026.05.032","url":null,"abstract":"<div><div>Psychiatry is distinguished by an approach that combines the contributions of the natural sciences and the humanities. It is neither a branch of neuroscience nor a branch of psychology, as it possesses a specific, primarily clinical, body of knowledge. In its therapeutic methods, it also integrates biology and psychotherapy. This is an opportunity to emphasize that medicine is not a science: guided by its millennia-old ethics, it is an art that stimulates scientific research and applies its findings. It must draw upon both the natural and human sciences to live up to its ambitions.</div></div>","PeriodicalId":55317,"journal":{"name":"Bulletin De L Academie Nationale De Medecine","volume":"210 8","pages":"Pages 963-968"},"PeriodicalIF":0.3,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149072000","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Stimulation cérébrale profonde dans le syndrome de Gilles de la Tourette 图雷特吉勒斯综合征的脑深部刺激
IF 0.3 4区 医学
Bulletin De L Academie Nationale De Medecine Pub Date : 2026-10-01 Epub Date: 2026-08-18 DOI: 10.1016/j.banm.2026.03.019
Yulia Worbe
{"title":"Stimulation cérébrale profonde dans le syndrome de Gilles de la Tourette","authors":"Yulia Worbe","doi":"10.1016/j.banm.2026.03.019","DOIUrl":"10.1016/j.banm.2026.03.019","url":null,"abstract":"<div><div>Gilles de la Tourette syndrome (GTS) is a neurodevelopmental disorder characterized by the presence of motor and vocal tics, frequently associated with psychiatric comorbidities, including obsessive–compulsive disorder, attention-deficit/hyperactivity disorder, and mood and anxiety disorders. Over the past decades, major advances have reshaped our understanding of the pathophysiology of GTS. Neuropathological, transcriptomic, and developmental studies now converge toward the presence of a marked deficit in striatal interneurons, arising from early disruptions in signaling pathways involved in basal ganglia development. This interneuronal loss leads to an imbalance between inhibitory and excitatory processes, impairing the selection and filtering of motor programs within cortico–striato–thalamo–cortical circuits. Therapeutic management of GTS follows a stepwise approach, with behavioral interventions and pharmacological treatments as first-line strategies. However, deep brain stimulation (DBS) has emerged as a last-resort therapeutic option for a small subset of patients with severe, disabling, and treatment-refractory forms of the disorder. Patient selection, as defined by the European Society for the Study of Tourette Syndrome (ESSTS) guidelines, relies on a rigorous multidisciplinary assessment encompassing tic severity, functional impairment, and stability of psychiatric comorbidities. While controlled clinical trials have supported the relevance of thalamic targets, particularly the centromedian–parafascicular complex, and pallidal targets such as the globus pallidus internus, recent research has shifted toward a network-based perspective and the characterization of oscillatory dynamics underlying tic generation. Although continuous open-loop stimulation remains the current clinical standard, cutting-edge research is now focusing on adaptive neuromodulation strategies. By leveraging the decoding of local field potentials (LFPs), feasibility studies have demonstrated the long-term stability of electrophysiological biomarkers, paving the way for personalized, real-time stimulation paradigms. These developments hold promise for optimizing the benefit–risk balance of DBS in the most complex and severely affected patients with GTS.</div></div>","PeriodicalId":55317,"journal":{"name":"Bulletin De L Academie Nationale De Medecine","volume":"210 8","pages":"Pages 933-938"},"PeriodicalIF":0.3,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149072002","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Communiqué. L’usage détourné du protoxyde d’azote, en augmentation importante et aux conséquences graves, doit être prévenu 公报。必须防止一氧化二氮的滥用,这种滥用正在急剧增加,并造成严重后果。
IF 0.3 4区 医学
Bulletin De L Academie Nationale De Medecine Pub Date : 2026-10-01 Epub Date: 2026-08-10 DOI: 10.1016/j.banm.2026.07.007
Académie nationale de médecine
{"title":"Communiqué. L’usage détourné du protoxyde d’azote, en augmentation importante et aux conséquences graves, doit être prévenu","authors":"Académie nationale de médecine","doi":"10.1016/j.banm.2026.07.007","DOIUrl":"10.1016/j.banm.2026.07.007","url":null,"abstract":"","PeriodicalId":55317,"journal":{"name":"Bulletin De L Academie Nationale De Medecine","volume":"210 8","pages":"Pages 888-889"},"PeriodicalIF":0.3,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149072012","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neurostimulation et pathologie du mouvement : approche médicale, de recherche, des patients, expérience et perspectives 神经刺激与运动病理学:医学方法、研究、患者、经验与观点
IF 0.3 4区 医学
Bulletin De L Academie Nationale De Medecine Pub Date : 2026-10-01 Epub Date: 2026-08-27 DOI: 10.1016/j.banm.2026.03.018
Jean-Philippe Azulay
{"title":"Neurostimulation et pathologie du mouvement : approche médicale, de recherche, des patients, expérience et perspectives","authors":"Jean-Philippe Azulay","doi":"10.1016/j.banm.2026.03.018","DOIUrl":"10.1016/j.banm.2026.03.018","url":null,"abstract":"<div><div>Parkinson's disease is a slowly progressive neurodegenerative disorder, the prognosis of which has been transformed by levodopa. After a few years, levodopa can lead to complications due to its short half-life, requiring continuous symptom control either by pump injection or deep brain stimulation (DBS). Much research has been devoted to determining the right stage of the disease to use these so-called second-line treatments and to help choose the most appropriate one. Although no studies have compared them, a number of arguments suggest that DBS is the most effective treatment, but also the one with the strictest selection criteria. DBS quickly took the place of lesion surgery, particularly in the treatment of tremor, as it reproduces the effects of lesion surgery while allowing for parameter adjustment. However, the possibility of performing targeted lesions in the brain without intracranial penetration using Gamma Knife or focused ultrasound has restored this indication, particularly for essential or Parkinson's tremor, by targeting the intermediate nucleus of the thalamus. However, like other treatments for Parkinson's disease, SCP remains purely symptomatic, but new techniques such as gene or cell therapy are beginning to develop and could change the management and prognosis of the disease in the coming years.</div></div>","PeriodicalId":55317,"journal":{"name":"Bulletin De L Academie Nationale De Medecine","volume":"210 8","pages":"Pages 927-932"},"PeriodicalIF":0.3,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149071995","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rapport 26-09. Dépistage génétique préconceptionnel 26-09报告。孕前基因检测
IF 0.3 4区 医学
Bulletin De L Academie Nationale De Medecine Pub Date : 2026-10-01 Epub Date: 2026-07-24 DOI: 10.1016/j.banm.2026.07.005
Jean-Louis Mandel, Florent Soubrier, au nom d’un groupe de travail de la commission 1 de l’Académie nationale de médecine (ANM)
{"title":"Rapport 26-09. Dépistage génétique préconceptionnel","authors":"Jean-Louis Mandel,&nbsp;Florent Soubrier,&nbsp;au nom d’un groupe de travail de la commission 1 de l’Académie nationale de médecine (ANM)","doi":"10.1016/j.banm.2026.07.005","DOIUrl":"10.1016/j.banm.2026.07.005","url":null,"abstract":"<div><div>The identification of hundreds of genes responsible for severe and incurable recessive genetic diseases in children (autosomal or X-linked) makes it possible to screen for carriers of mutations in these genes using molecular genetics methods. Carrier screening performed before conception in both partners of a couple can determine whether they are at high risk of having a child affected by a recessive genetic disease and allows prospective parents to be informed about the options available to them to address this risk. The report addresses the various aspects of preconception genetic screening (PGS), including ethical, technical, regulatory and legal, as well as medico-economic considerations. The French National Academy of Medicine considers that PGS is consistent with other reproductive choices already authorized in France (prenatal diagnosis and preimplantation genetic testing) and that it should be permitted in France.</div></div>","PeriodicalId":55317,"journal":{"name":"Bulletin De L Academie Nationale De Medecine","volume":"210 8","pages":"Pages 879-886"},"PeriodicalIF":0.3,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149072005","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书